|
CD2AP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.294800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.726100E-02 |
| Normal-vs-Stage2 |
3.328600E-01 |
| Normal-vs-Stage3 |
9.548800E-01 |
| Normal-vs-Stage4 |
8.955600E-01 |
| Stage1-vs-Stage2 |
7.350200E-01 |
| Stage1-vs-Stage3 |
1.650220E-01 |
| Stage1-vs-Stage4 |
2.685600E-01 |
| Stage2-vs-Stage3 |
5.097600E-01 |
| Stage2-vs-Stage4 |
4.861200E-01 |
| Stage3-vs-Stage4 |
9.008200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.494000E-02 |
| Normal-vs-AfricanAmerican |
8.486200E-01 |
| Normal-vs-Asian |
4.867200E-01 |
| Caucasian-vs-AfricanAmerican |
1.672620E-01 |
| Caucasian-vs-Asian |
9.186200E-01 |
| AfricanAmerican-vs-Asian |
3.867800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.686000E-02 |
| Normal-vs-Female |
4.342600E-01 |
| Male-vs-Female |
5.998200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.380960E-01 |
| Normal-vs-Extreme_Weight |
8.198500E-03 |
| Normal-vs-Obese |
6.296200E-01 |
| Normal-vs-Extreme_Obese |
1.255590E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.026000E-01 |
| Normal_Weight-vs-Obese |
7.837600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.643800E-01 |
| Extreme_Weight-vs-Obese |
3.501600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.795800E-01 |
| Obese-vs-Extreme_Obese |
8.048500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.617400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.076600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.962400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.336000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.210780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.649700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.136100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.373700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.787780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.247000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.224200E-01 |
| Normal-VS-Type2 PRCC |
2.604400E-01 |
| Normal-VS-KIRP CIMP |
9.260200E-02 |
| Normal-VS-Unclassified PRCC |
6.455200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.152600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.764200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.107000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.491600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.393400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.315900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.605750E-02 |
| Normal-vs-N1 |
5.174100E-02 |
| Normal-vs-N2 |
1.962960E-01 |
| N0-vs-N1 |
8.018600E-03 |
| N0-vs-N2 |
9.085400E-01 |
| N1-vs-N2 |
1.874330E-02 |
|
|
